The statistics for Alzheimer’s disease-related deaths dwarf the casualties of the COVID-19 pandemic. More than 1 million Americans have died of COVID-19, but about 45 million Americans will die of ...

Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...

A research team from Indiana University School of Medicine has mapped subtle patterns in brain function that appear long ...

The damage caused by Alzheimer's disease begins long before any symptoms show up. Over the course of years or decades in this preclinical stage, the characteristic buildup of disease-causing amyloid ...

Dementia is a broad term for memory loss and other cognitive issues, such as language and problem-solving problems, that can interfere with daily life. Alzheimer’s disease is one type of dementia.

The early stages of Alzheimer's disease often involve an insidious decline in short-term memory, along with mounting ...

Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in ...

In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

The results from the two trials of early-stage Alzheimer's patients, called EVOKE and EVOKE+, are another setback for the ...

Either we get ahead of the Alzheimer’s crisis or watch a generation swept into the devastating grip of disease, former CDC Director Dr. Robert R. Redfield writes in a Chicago Tribune ...